982 related articles for article (PubMed ID: 31806649)
1. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
[TBL] [Abstract][Full Text] [Related]
2. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetologia; 2020 Feb; 63(2):229-241. PubMed ID: 31802144
[TBL] [Abstract][Full Text] [Related]
3. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies.
Sherr JL; Tauschmann M; Battelino T; de Bock M; Forlenza G; Roman R; Hood KK; Maahs DM
Pediatr Diabetes; 2018 Oct; 19 Suppl 27():302-325. PubMed ID: 30039513
[No Abstract] [Full Text] [Related]
4. 7. Diabetes Technology:
American Diabetes Association
Diabetes Care; 2020 Jan; 43(Suppl 1):S77-S88. PubMed ID: 31862750
[TBL] [Abstract][Full Text] [Related]
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE
Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046
[TBL] [Abstract][Full Text] [Related]
6. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.
Galindo RJ; Umpierrez GE; Rushakoff RJ; Basu A; Lohnes S; Nichols JH; Spanakis EK; Espinoza J; Palermo NE; Awadjie DG; Bak L; Buckingham B; Cook CB; Freckmann G; Heinemann L; Hovorka R; Mathioudakis N; Newman T; O'Neal DN; Rickert M; Sacks DB; Seley JJ; Wallia A; Shang T; Zhang JY; Han J; Klonoff DC
J Diabetes Sci Technol; 2020 Nov; 14(6):1035-1064. PubMed ID: 32985262
[TBL] [Abstract][Full Text] [Related]
7. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
[TBL] [Abstract][Full Text] [Related]
8. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
[TBL] [Abstract][Full Text] [Related]
9. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
Diabetologia; 2023 Jan; 66(1):3-22. PubMed ID: 36198829
[TBL] [Abstract][Full Text] [Related]
10. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
Diabetes Care; 2022 Dec; 45(12):3058-3074. PubMed ID: 36202061
[TBL] [Abstract][Full Text] [Related]
11. A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes.
Choudhary P; Campbell F; Joule N; Kar P;
Diabet Med; 2019 May; 36(5):531-538. PubMed ID: 30773681
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of apps for patients.
Ahn DT
Curr Opin Endocrinol Diabetes Obes; 2022 Feb; 29(1):17-22. PubMed ID: 34878413
[TBL] [Abstract][Full Text] [Related]
13. USA Vs Europe: Who Is Leading the Diabetes Tech Race?
Acosta GJ; Brown S; Zand AM; Kansara A; Sadhu A
Curr Diab Rep; 2019 Nov; 19(11):128. PubMed ID: 31734741
[TBL] [Abstract][Full Text] [Related]
14. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.
Blevins TC; Bode BW; Garg SK; Grunberger G; Hirsch IB; Jovanovič L; Nardacci E; Orzeck EA; Roberts VL; Tamborlane WV; ; Rothermel C
Endocr Pract; 2010; 16(5):730-45. PubMed ID: 21356637
[No Abstract] [Full Text] [Related]
15. Bluetooth Wireless Technology Cybersecurity and Diabetes Technology Devices.
Saltzstein W
J Diabetes Sci Technol; 2020 Nov; 14(6):1111-1115. PubMed ID: 31319701
[TBL] [Abstract][Full Text] [Related]
16. EASD diabetes technology meeting: medical associations are on track.
Heinemann L
J Diabetes Sci Technol; 2014 Jul; 8(4):900-3. PubMed ID: 24876444
[TBL] [Abstract][Full Text] [Related]
17. App-Based Insulin Calculators: Current and Future State.
Eiland L; McLarney M; Thangavelu T; Drincic A
Curr Diab Rep; 2018 Oct; 18(11):123. PubMed ID: 30284645
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
Chamberlain JJ; Doyle-Delgado K; Peterson L; Skolnik N
Ann Intern Med; 2019 Sep; 171(6):415-420. PubMed ID: 31404925
[TBL] [Abstract][Full Text] [Related]
19. IDF Europe's position on mobile applications in diabetes.
Rose KJ; Petrut C; L'Heveder R; de Sabata S
Diabetes Res Clin Pract; 2019 Mar; 149():39-46. PubMed ID: 28951337
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
